title: Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.
authors.affiliation: Department of General Surgery and Transplantation, University Hospital Essen, Essen, Germany. susanne.beckebaum@uni-essen.de
authors.forename: S
authors.initials: S
authors.lastname: Beckebaum
authors.forename: V R
authors.initials: VR
authors.lastname: Cicinnati
authors.forename: M
authors.initials: M
authors.lastname: Karliova
authors.forename: O
authors.initials: O
authors.lastname: Dirsch
authors.forename: Y
authors.initials: Y
authors.lastname: Erim
authors.forename: A
authors.initials: A
authors.lastname: Frilling
authors.forename: M
authors.initials: M
authors.lastname: Malago
authors.forename: C E
authors.initials: CE
authors.lastname: Broelsch
authors.forename: U
authors.initials: U
authors.lastname: Treichel
authors.forename: G
authors.initials: G
authors.lastname: Gerken
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications / Q000188:drug therapy / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D012254:Ribavirin